-
Navigating the Transition: What EU JCA Means for AMNOG Submissions in 2025 and Beyond
Sep 9, 2025, 16:22 PM -
Positioning of the Eluvia™, Drug-Eluting Stent in the Treatment of Peripheral Artery Disease (PAD) in Türkiye: Insights From a Specialist Panel Survey and Focus Group Study
Sep 9, 2025, 16:22 PM -
Real-World Associations Between Smoking Status and Genetic Driver Mutations in Metastatic Lung Cancer in US Community Oncology
Sep 9, 2025, 16:22 PM -
Development of a Multidimensional HTA Evaluation for the Introduction of Clesrovimab in Pediatric RSV Prevention: An Integrated Methodological Approach
Sep 9, 2025, 16:22 PM -
Shifts in Medicine Reimbursement in Türkiye: Who Pays for Medicines (2015-2022)?
Sep 9, 2025, 16:22 PM -
UDCA Treatment Response in Primary Biliary Cholangitis in the United States
Sep 9, 2025, 16:22 PM -
A Long and Winding Road: An Evaluation of NICE HST Appraisals Taking Longer Than Two Years for Guidance Publication
Sep 9, 2025, 16:22 PM -
Economic Burden of Chronic Obstructive Pulmonary Disease (COPD) in India: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Colorectal Cancer Mortality Overview in Mexico 1998-2023
Sep 9, 2025, 16:22 PM -
Quantifying the Economic Burden of Undiagnosed Sleep Apnea in India’s Productive Population: A Health Economic Modeling Approach
Sep 9, 2025, 16:22 PM -
Addressing the Impact of Alzheimer’s Disease on Care Capacity in the Netherlands: Implications for Health Technology Assessment
Sep 9, 2025, 16:22 PM -
Similarities and Differences Between the National Institute for Health and Care Excellence (NICE) and European Union Joint Clinical Assessment (EU JCA) Clinical Systematic Literature Review Requirements
Sep 9, 2025, 16:22 PM -
Comparing Health-Related Quality of Life in Obese Patients With and Without Bariatric Surgery: A Cross-Sectional Study in a Multi-Ethnic Asian Population in Singapore
Sep 9, 2025, 16:22 PM -
Respiratory Syncytial Virus (RSV) Knowledge and Perceived RSV Risk Groups Amongst GP/PCPs and Specialists in APAC: A Cross-Sectional Knowledge Attitude and Practices Survey (RESVIKAP)
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Disease Progression in Patients With Primary Hyperoxaluria: A Retrospective Cohort Study
Sep 9, 2025, 16:22 PM -
Methodological Insights From Recent PBAC Recommendations to Support Biosimilar Reimbursement in Australia
Sep 9, 2025, 16:22 PM -
Caregiver Quality of Life in Orphan Drug Health Technology Assessment Submissions in Europe: A Comparative Analysis
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Introducing the Elecsys® PRO-C3 Assay as Part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK
Sep 9, 2025, 16:22 PM -
Health Equity Considerations in Economic Evaluation: Comparative Acceptability and Application Across European HTA Bodies
Sep 9, 2025, 16:22 PM -
Is Lecanemab Worth the Wait? Real Option Value and the Cost of Future Innovation in Alzheimer's Disease
Sep 9, 2025, 16:22 PM
